Similarly, our Western blot data suggested that elevated circulating TMAO could downregulate synaptic plasticity-associated proteins, including synaptophysin, MAP-2, and PSD-95, which led to cognitive deficits in the rats. The gene discussed is MAP2; the disease is Cognitive impairment.